Skip to content

Infinitus brand Zhenyuan capsule enhances immune function on human body with TCM syndrome differentiating health care characteristic

Infinitus brand Zhenyuan capsule enhances immune function on human body with TCM syndrome differentiating health care characteristic

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061534
Enrollment
Unknown
Registered
2022-06-28
Start date
2022-06-28
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoimmunity

Interventions

Intervention Group:Infinitus brand Zhenyuan capsule

Sponsors

CoNo Technology Group
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 18-65 years old; 2. Physically weak and prone to disease: meet one of them: (1) Cold >= 3 times a year; (2) Bronchitis or pneumonia >= 2 times a year; (3) Is prone to acute diarrhea (except lactose, gluten and other food intolerance) >= 3 times a year. 3. Voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with immune-related diseases and tumors; 2. Due to the decline of immune function caused by taking drugs; 3. Those who are allergic to the ingredients of the health food; 4. Women who are planning to become pregnant, pregnant or breastfeeding; 5. Subjects with severe heart, brain, liver, kidney, hematopoietic system diseases, severe occupational diseases and mental illness; 6. Those who have taken products that affect immune function within 4 weeks before the start of the food trial, which affects the judgment of the results.

Design outcomes

Primary

MeasureTime frame
Syndromes Scale;TCM Syndromes Scale;

Secondary

MeasureTime frame
36-Item Short Form Survey (SF-36);

Countries

China

Contacts

Public ContactYang Yi

CoNo Technology Group

yangyi@kaotg.com+86 18622281699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026